The antibody targets a stable part of the bird flu virus, ensuring that the immune protection can resist new variants and offer long-term protection against the globally spreading airborne infection.

A prophylactic antibody-based immune therapy protects monkeys against severe disease caused by H5N1 avian flu, University of ...

A new antibody therapy effectively protects monkeys from severe H5N1 avian flu, offering hope for a universal flu vaccine and ...

The antibodies target a stable part of the bird flu virus, ensuring that the immune protection can resist new variants and ...

The research team, studying the efficacy of a preventive antibody-based therapy, found it successfully protects monkeys from ...

A prophylactic antibody-based immune therapy has been shown to protect monkeys against severe bird flu caused by H1N1.

The highly pathogenic avian influenza H5N1 infection has killed millions of birds around the world, and has spread to humans ...

Scientists found that a moderate dose of MEDI8852, an antibody therapy, effectively protected monkeys against severe H5N1 avian flu.

"This type of prevention can be very useful in controlling infection outbreaks and containing the bird flu pandemic," said an immunologist.